January 11, 2019
Article
The section chief of pediatric neurology at Nationwide Children’s Hospital shared his excitement about the approval of Epidiolex and its potential as a therapeutic.
The Success of the Jefferson Mobile Stroke Unit: Alvin Wang, DO, BC-EMS
Progress in Neurogenerative Disease Drug Development: Gregory A. Rippon, MD, MS
Diazepam Nasal Spray Significantly Extends Time Between Seizure Clusters
Reactions to FDA Advisory Panel Decision on AMX0035: Justin Klee; Josh Cohen, BSc